Evidence map›Paper›PMID 21763300›Full record

ArticleClinical biochemistry2011

Lateral flow assay for simultaneous detection of cellular- and humoral immune responses.

Paul L A M Corstjens, Claudia J de Dood, Jolien J van der Ploeg-van Schip, Karien C Wiesmeijer, Terhi Riuttamäki, Krista E van Meijgaarden, John S Spencer, Hans J Tanke, Tom H M Ottenhoff, Annemieke Geluk

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Clinical biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Engineering Innovative Interfaces for Point-of-Care Diagnostics.Current opinion in colloid & interface science · 2023
    Review
  5. Article
  6. Lateral Flow Microarray-Based ELISA for Cytokines.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Paul L A M CorstjensDepartment of Molecular Cell Biology Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. P.Corstjens@LUMC.NL
Claudia J de Dood
Jolien J van der Ploeg-van Schip
Karien C Wiesmeijer
Terhi Riuttamäki
Krista E van Meijgaarden
John S Spencer
Hans J Tanke
Tom H M Ottenhoff
Annemieke Geluk
Leiden University Medical Center · NLColorado State University · USUniversity of Turku · FI

Funding

Point Detection of Pathogens in Oral Samples via UPTU01DE017855 · NIDCR · NEW YORK UNIVERSITY · PI MALAMUD, DANIEL · 2006 to 2010
$7.9M
NIDCR NIH HHS U01 DE017855NIDCR NIH HHS U01DE017855
6 · The paper itself

Abstract

objectiveThe development of a cytokine detection assay suitable for detection of multiple biomarkers for improved diagnosis of mycobacterial diseases. DESIGN AND

methodsA lateral flow (LF) assay to detect IL-10 was developed utilizing the up-converting phosphor (UCP) reporter-technology. The assay was evaluated using blood samples of leprosy patients. Multiplex applications were explored targeting: 1) IL-10 and IFN-γ in assay buffer; 2) IL-10 and anti-phenolic glycolipid (PGL-I) antibodies in serum from leprosy patients.

resultsDetection of IL-10 below the targeted level of 100pg/mL in serum was shown. Comparison with ELISA showed a quantitative correlation with R(2) value of 0.92. Multiplexing of cytokines and simultaneous detection of cytokine and antibody was demonstrated.

conclusionsThe UCP-LF IL-10 assay is a user-friendly, rapid alternative for IL-10 ELISAs, suitable for multiplex detection of different cytokines and can be merged with antibody-detection assays to simultaneously detect cellular- and humoral immunity.

Indexed as

Antigens, BacterialBiological AssayBiomarkersBuffersCytokinesEnzyme-Linked Immunosorbent AssayGlycolipidsHumansImmunity, HumoralInterferon-gammaInterleukin-10LeprosyMycobacterium InfectionsReference ValuesSensitivity and SpecificityAntigens, BacterialBiomarkersBuffersCytokinesGlycolipidsIL10 protein, humanInterferon-gammaInterleukin-10phenolic glycolipid I, Mycobacterium leprae

Identifiers

PMID21763300
PMCPMC3177995
OpenAlexW2042429246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.